Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025)
Pulse Biosciences' (PLSE) quarterly Cash from Investing Activities came in at -$105000.0 in Q4 2025, down 98.11% year-on-year from -$5.6 million in Q4 2024, and down 69.35% quarter-over-quarter from -$62000.0 in Q3 2025.
Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Pulse Biosciences' Cash from Investing Activities history runs 11 years deep, the most recent figure standing at -$105000.0 for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 98.11% year-over-year to -$105000.0 in Q4 2025; TTM through Dec 2025 was -$335000.0, a 168.0% decrease from a year earlier, with the FY2025 full-year figure at -$335000.0, down 168.0% from the prior year.
- Cash from Investing Activities declined to -$105000.0 in Q4 2025 per PLSE's latest filing, from -$62000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7.9 million in Q1 2021 and bottomed at -$279000.0 in Q1 2022.
- The 5-year median for Cash from Investing Activities is -$44000.0 (2023), against an average of $329050.0.
- Across the five-year window, Cash from Investing Activities jumped 99.3% in 2021 and plunged 800.0% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$134000.0 in 2021, then soared by 69.4% to -$41000.0 in 2022, then fell by 4.88% to -$43000.0 in 2023, then declined by 23.26% to -$53000.0 in 2024, then tumbled by 98.11% to -$105000.0 in 2025.
- Per Business Quant, the three latest PLSE Cash from Investing Activities figures stand at -$105000.0 (Q4 2025), -$62000.0 (Q3 2025), and -$123000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Pulse Biosciences | 2.23 Bn | 2.15 Bn | - | -105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Sep 30, 2023 | -23,000.00 |
| Sep 30, 2023 | -23,000.00 |